Frédéric Lioté

机构：Inserm, Université Paris Cité, Hôpital Lariboisière · ORCID：0000-0003-4419-0726

发表论文 577 篇 · 总被引 18546 次 · h-index 67

代表论文

• Mechanisms and rationale for uricase use in patients with gout (2023 · Nature Reviews Rheumatology · 被引 110)
• Calcium pyrophosphate deposition disease (2024 · The Lancet Rheumatology · 被引 101)
• A genome-wide association analysis reveals new pathogenic pathways in gout (2024 · Nature Genetics · 被引 95)
• The 2023 ACR/ EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease (2023 · Arthritis & Rheumatology · 被引 83)
• The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease (2023 · Annals of the Rheumatic Diseases · 被引 75)
• The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout (2024 · Nature Reviews Rheumatology · 被引 38)